ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PGNY vs AGL // EV/EBITDA & P/E VALUATION

Progyny Inc. (NASDAQ) VS. agilon health inc. (NYSE) • 15-METRIC TALLY: PGNY 9 — AGL 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PGNY VS. AGL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PGNY AGL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 23.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 16.70% -35.00% +51.70 PGNY /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 20.5x — — TIE /valuation <GO>
Free Cash Flow Yield 8.80% -8.25% +17.05 PGNY /fcf-yield <GO>
Operating Margin 6.60% -7.80% +14.40 PGNY /operating-margins <GO>
Net Profit Margin 4.50% -6.60% +11.10 PGNY /net-margins <GO>
Revenue Growth (YoY) 10.40% -2.10% +12.50 PGNY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.84 2.06 +6.78 PGNY /balance-sheet <GO>
Piotroski F-Score Quality 7/9 3/9 +4.00 PGNY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.0 44.0 +18.01 PGNY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 34.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.18B $1.44B $736.0M PGNY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PGNY REV AGL REV PGNY GROSS % AGL GROSS % PGNY FCF AGL FCF
FY 2025 $1.29B $5.93B 23.6% — $191.8M -$119.0M
FY 2024 $1.17B $6.06B 21.7% — $173.7M -$71.0M
FY 2023 $1.09B $4.32B — — $188.8M -$156.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PGNY // BETA —
AGL // BETA —